Initial hiccups in Bharat Biotech Bengaluru plant delayed Covaxin production: NTAGI Chief

'The test batches of that plant weren't satisfactory and got rejected which led to delay in ramping up production,' says Dr N K Arora.He also said that Bharat Biotech will be able to ramp up almost 7-10 crore doses of its Covid vaccine in the coming weeks

from mint - News https://ift.tt/3jljYnM
https://ift.tt/eA8V8J